A folate receptor 3 SNP promotes mitochondria-induced clonogenicity of CML leukemia cells : Implications for treatment free remission
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:11 |
|---|---|
| Enthalten in: |
Clinical and translational medicine - 11(2021), 2 vom: 03. Feb., Seite e317 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Shen, Na [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Carrier Proteins |
|---|
| Anmerkungen: |
Date Completed 23.12.2021 Date Revised 23.12.2021 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1002/ctm2.317 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM321931297 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM321931297 | ||
| 003 | DE-627 | ||
| 005 | 20231225180941.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/ctm2.317 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1073.xml |
| 035 | |a (DE-627)NLM321931297 | ||
| 035 | |a (NLM)33634983 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Shen, Na |e verfasserin |4 aut | |
| 245 | 1 | 2 | |a A folate receptor 3 SNP promotes mitochondria-induced clonogenicity of CML leukemia cells |b Implications for treatment free remission |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 23.12.2021 | ||
| 500 | |a Date Revised 23.12.2021 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 7 | |a Carrier Proteins |2 NLM | |
| 650 | 7 | |a FOLR3 protein, human |2 NLM | |
| 700 | 1 | |a Liu, Teng |e verfasserin |4 aut | |
| 700 | 1 | |a Liu, Wen |e verfasserin |4 aut | |
| 700 | 1 | |a Zhong, Zhaodong |e verfasserin |4 aut | |
| 700 | 1 | |a Li, Qing |e verfasserin |4 aut | |
| 700 | 1 | |a Zhu, Xiaoying |e verfasserin |4 aut | |
| 700 | 1 | |a Zou, Ping |e verfasserin |4 aut | |
| 700 | 1 | |a You, Yong |e verfasserin |4 aut | |
| 700 | 1 | |a Guo, An-Yuan |e verfasserin |4 aut | |
| 700 | 1 | |a Zhu, Xiaojian |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical and translational medicine |d 2012 |g 11(2021), 2 vom: 03. Feb., Seite e317 |w (DE-627)NLM224642685 |x 2001-1326 |7 nnns |
| 773 | 1 | 8 | |g volume:11 |g year:2021 |g number:2 |g day:03 |g month:02 |g pages:e317 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/ctm2.317 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 11 |j 2021 |e 2 |b 03 |c 02 |h e317 | ||